Cerep SA (EPA:CER) to Release Preliminary 2007 Earnings March 28

Cerep SA (EPA:CER) will release the preliminary earnings for 2007 on Friday, March 28.

Headquartered in Paris, Cerep SA specializes in the development and discovery of new pharmaceutical drugs.  By using its BioPrint technology systems, the company can analyze pharmaceutical drugs on the market, drugs that have been withdrawn from the market and drugs that failed while in development.  BioPrint also builds predictive models of potential new drugs.  Predictions are based on the chemical structure of the drug and their in vitro performance.

The company also provides time and cost solutions to the pharmaceutical and biotechnology sectors.

Cerep operates Hesperion Ltd, a Swiss company focused on clinical development of drugs, and Anceris SA, focused on drug discovery for oncology.

Cerep SA (EPA:CER)

For more Earnings related events or to post your own events, visit: